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Background
Many patients with malignant cardiac arrhythmias’
require thorough investigations to determine the etiol-
ogy. Conventional tests (ECG and echocardiography)
often cannot detect a structural basis for the arrhythmia
and physicians therefore lack guidance as to the most
appropriate treatment.
Previous studies have shown MRI is a more sensitive
and specific modality to better elucidate cardiac
abnormalities and provide insight to the underlying
etiology and better predict clinical outcomes.
Hypothesis
Compared to conventional testing, Cardiac MRI has
incremental benefit in the diagnosis and treatment of
patients with ventricular tachycardia and in the assess-
ment/treatment of patients with suspected ARVD.
Methods
We performed a retrospective review of patients who
have undergone CMR as part of their treatment/workup
for ventricular arrhythmias and/or ARVD at the Univer-
sity of Alberta Hospital over the last 4 years. CMR
results were correlated to patient outcomes: death, car-
diac death, hospital admissions, ICD implantation, and
electrophysiologic ablation
Results
A total of 211 patients were enrolled; however complete
clinical data on only 142 patients was obtained. The base-
line age/sex was 46 years & 59% male. The average BSA
was 1.86m^2. Known CAD was documented in 9.8%.
The presenting symptom(s) to medical attention are as
follows: Syncope 36.6%, Palpitation 36.6%, Arrest 9.2%,
None 17.6%. The arrhythmia’s documented upon patient
review were Atrial Tachycardia 2.8%, 10.5%, NSVT
28.8%, VT 31.7%, and VF 5.6%, None 20.6%)
Based on the clinical presentation 55% of patients
were admitted to hospital, 37% went on to have an EPS
procedure. There were 12 cardiac arrests at presentation
that received an ICD. A further 6% who did not arrest
also received an ICD
The corresponding Ejection fractions can be seen in
Table 1.
In terms of ARVD, a diagnosis was made in 2.1% of
the patients via CMR while 8.4% of the patients pos-
sessed one minor criterion. No diagnosis of ARVD was
made on echocardiography or EKG
Conclusion
CMR’s increased sensitivity is able to detect many more
abnormalities but these rarely translate into changes in clin-
ical practice unless in the context of a diagnosis of ARVD.
Although a normal CMR is reassuring and likely precludes
a favorable outcome 1/3 of patients still underwent further
EPS testing with ½ of those resulting in no further interven-
tion. This details that CMR may be a more sensitive tool to
exclude malignant causes of ventricular arrhythmia but this
has not changed current practice patterns.
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Table 1 Average Ejection fraction based on Imaging
Modality
Echo CMR Atypical Gadolinium uptake
LVEF% 52.82 60.36% 58.2%
RVEF% Normal 55.2% 53%
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